<SEC-DOCUMENT>0001213900-23-000003.txt : 20230103
<SEC-HEADER>0001213900-23-000003.hdr.sgml : 20230103
<ACCEPTANCE-DATETIME>20230103060237
ACCESSION NUMBER:		0001213900-23-000003
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20221230
FILED AS OF DATE:		20230103
DATE AS OF CHANGE:		20230103

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Stilley William B. III
		CENTRAL INDEX KEY:			0001718069

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38323
		FILM NUMBER:		23500040

	MAIL ADDRESS:	
		STREET 1:		1180 SEMINOLE TRAIL, SUITE 495
		CITY:			CHARLOTTESVILLE
		STATE:			VA
		ZIP:			22901

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ADIAL PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001513525
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				800667150
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1180 SEMINOLE TRAIL
		STREET 2:		SUITE 495
		CITY:			CHARLOTTESVILLE
		STATE:			VA
		ZIP:			22901
		BUSINESS PHONE:		434-422-9800

	MAIL ADDRESS:	
		STREET 1:		1180 SEMINOLE TRAIL
		STREET 2:		SUITE 495
		CITY:			CHARLOTTESVILLE
		STATE:			VA
		ZIP:			22901

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADial Pharmaceuticals, L.L.C.
		DATE OF NAME CHANGE:	20170515

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adial Pharmaceuticals, L.L.C.
		DATE OF NAME CHANGE:	20110218
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2022-12-30</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001513525</issuerCik>
        <issuerName>ADIAL PHARMACEUTICALS, INC.</issuerName>
        <issuerTradingSymbol>ADIL</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001718069</rptOwnerCik>
            <rptOwnerName>Stilley William B. III</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>1180 SEMINOLE TRAIL, SUITE 495</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>CHARLOTTESVILLE</rptOwnerCity>
            <rptOwnerState>VA</rptOwnerState>
            <rptOwnerZipCode>22901</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2022-12-30</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>D</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness></transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>166667</value>
                    <footnoteId id="F1"/>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>1020979</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">Represents the cancellation of 166,667 previously outstanding shares of restricted common stock of Adial Pharmaceuticals, Inc. originally issued on February 23, 2022.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ William B. Stilley, III</signatureName>
        <signatureDate>2023-01-03</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
